| Literature DB >> 36012211 |
Ekeveliny Amabile Veschi1, Maytê Bolean1, Luiz Henrique da Silva Andrilli1, Heitor Gobbi Sebinelli1, Agnieszka Strzelecka-Kiliszek2, Joanna Bandorowicz-Pikula2, Slawomir Pikula2, Thierry Granjon3, Saida Mebarek3, David Magne3, José Luis Millán4, Ana Paula Ramos1, Rene Buchet3, Massimo Bottini1,5, Pietro Ciancaglini1,5.
Abstract
The biochemical machinery involved in matrix vesicles-mediated bone mineralization involves a specific set of lipids, enzymes, and proteins. Annexins, among their many functions, have been described as responsible for the formation and stabilization of the matrix vesicles' nucleational core. However, the specific role of each member of the annexin family, especially in the presence of type-I collagen, remains to be clarified. To address this issue, in vitro mineralization was carried out using AnxA6 (in solution or associated to the proteoliposomes) in the presence or in the absence of type-I collagen, incubated with either amorphous calcium phosphate (ACP) or a phosphatidylserine-calcium phosphate complex (PS-CPLX) as nucleators. Proteoliposomes were composed of 1,2-dipalmitoylphosphatidylcholine (DPPC), 1,2-dipalmitoylphosphatidylcholine: 1,2-dipalmitoylphosphatidylserine (DPPC:DPPS), and DPPC:Cholesterol:DPPS to mimic the outer and the inner leaflet of the matrix vesicles membrane as well as to investigate the effect of the membrane fluidity. Kinetic parameters of mineralization were calculated from time-dependent turbidity curves of free Annexin A6 (AnxA6) and AnxA6-containing proteoliposomes dispersed in synthetic cartilage lymph. The chemical composition of the minerals formed was investigated by Fourier transform infrared spectroscopy (FTIR). Free AnxA6 and AnxA6-proteoliposomes in the presence of ACP were not able to propagate mineralization; however, poorly crystalline calcium phosphates were formed in the presence of PS-CPLX, supporting the role of annexin-calcium-phosphatidylserine complex in the formation and stabilization of the matrix vesicles' nucleational core. We found that AnxA6 lacks nucleation propagation capacity when incorporated into liposomes in the presence of PS-CPLX and type-I collagen. This suggests that AnxA6 may interact either with phospholipids, forming a nucleational core, or with type-I collagen, albeit less efficiently, to induce the nucleation process.Entities:
Keywords: annexin A6; apatite; biomineralization; matrix vesicle mimetic model; proteoliposome
Mesh:
Substances:
Year: 2022 PMID: 36012211 PMCID: PMC9409191 DOI: 10.3390/ijms23168945
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Biophysical properties of liposomes and proteoliposomes constituted by different lipids. The diameters were obtained by DLS in triplicate assays, as described in Section 3, and PI is a polydispersion index. “-“ indicate the absence of AnxA6.
| Liposome/ | AnxA6 | Diameter (nm) | PI |
|---|---|---|---|
|
| - | 132.2 ± 8.0 | 0.08 |
| + | 130.6 ± 1.7 | 0.04 | |
|
| - | 114.4 ± 0.7 | 0.06 |
| + | 117.9 ± 0.9 | 0.07 | |
|
| - | 199.1 ± 1.1 | 0.08 |
| + | 199.5 ± 1.4 | 0.09 |
Figure 1Mineralization curves of proteoliposomes harboring AnxA6 with ACP nucleator. (A) Absence of type-I collagen; (B) Presence of type-I collagen. Change with time of the value of absorbance at 340 nm of different compositions of proteoliposomes harboring AnxA6. In blue—DPPC; orange—9:1 DPPC:DPPS; black—5:4:1 DPPC:Chol:DPPS; and green—control: AnxA6 in solution.
Figure 2Mineralization curves of proteoliposomes harboring AnxA6 with PS–CPLX nucleator. (A) Absence of type-I collagen; (B) presence of type-I collagen. Change with time of the value of absorbance at 340 nm of different compositions of proteoliposomes harboring AnxA6. Blue—DPPC; Orange—9:1 DPPC:DPPS; Black—5:4:1 DPPC:Chol:DPPS; and Green—Control: AnxA6 in solution.
The slope of the monotone increase in turbidity and the kinetic parameters of the nucleation process adjusted by the subtraction of monotone process (Supplementary Figures S1–S3), obtained from the mineralization curves for proteoliposomes and for AnxA6 (control) after 30 h of assay in SCL medium containing PS–CPLX in the absence of type-I collagen. Data are reported as the mean ± SD of triplicate measurements of three different proteoliposome preparations.
| Proteoliposome | Parameters | |||||
|---|---|---|---|---|---|---|
| Lipid Composition | Monotone Slope | ti | tf | tmax rate | Umax | PMP |
|
| 0.0084 | 9.5 ± 0.54 | 24.8 ± 0.56 | 18.5 ± 0.28 | 0.19 ± 0.05 | 0.010 |
|
| 0.0022 | 14.9 ± 0.39 | 24.3 ± 0.18 | 22.9 ± 0.35 | 0.15 ± 0.05 | 0.007 |
|
| 0.0013 | 10.7 ± 0.15 | 22.5 ± 0.34 | 19.5 ± 0.55 | 0.22 ± 0.09 | 0.011 |
|
| - | 20.7 ± 0.41 | 24.5 ± 0.32 | 22.4 ± 0.21 | 0.42 ± 0.03 | 0.019 |
Legend: ti, initial time of mineral formation; tf, final time of mineral formation; tmax rate, time at maximum rate of mineral formation; Umax, maximum value of turbidity; PMP = Umax/tmax rate, potential of mineral propagation.
Kinetic parameters of the nucleation process obtained from the mineralization curves for proteoliposomes and AnxA6 in solution (control), after 30 h of assay in SCL medium containing PS–CPLX in the presence of type-I collagen. Data are reported as the mean ± SD of triplicate measurements of three different proteoliposome preparations.
| Proteoliposome | Parameters | ||||
|---|---|---|---|---|---|
| ti | tf | tmax rate (h) | Umax | PMP | |
|
| 14.9 ± 0.40 | 27.5 ± 0.89 | 20.5 ± 0.63 | 0.33 ± 0.05 | 0.016 |
|
| 15.2 ± 0.44 | 29.5 ± 0.57 | 23.2 ± 0.22 | 0.39 ± 0.07 | 0.017 |
|
| 13.8 ± 0.28 | 29.9 ± 0.55 | 21.7 ± 0.39 | 0.38 ± 0.02 | 0.018 |
|
| ND | ND | ND | ND | ND |
Legend: ND, the curve did not fit; ti, initial time of mineral formation; tf, final time of mineral formation; tmax rate, time at maximum rate of mineral formation; Umax, maximum value of turbidity; PMP = Umax/tmax rate, potential of mineral propagation.
Figure 3ATR—FTIR spectra of the minerals produced by proteoliposomes harboring AnxA6 after 30 h of incubation in SCL in absence of type-I collagen. Blue—DPPC; Orange—9:1 DPPC:DPPS; Black—5:4:1 DPPC:Chol:DPPS; and Green—Control: AnxA6 in solution.
Ratios between the intensity of the bands at 1040 (PO43−) and 987 (HPO32−) cm−1 calculated from the ATR-FTIR spectra (Figure 3) of the mineral precipitated in the in vitro mineralization assay by the AnxA6—containing proteoliposomes and AnxA6 in solution, as a control, in the absence of type-I collagen.
| Proteoliposome | PO43−/HPO42− |
|---|---|
| DPPC | 1.2 |
| DPPC:DPPS (9:1) | 0.79 |
| DPPC:Chol:DPPS (5:4:1) | 0.64 |
| Control | 0.95 |
Figure 4Circular dichroism spectra for AnxA6 (2 µg·mL−1) at different pH values. Insertion: Relative molar ellipticity as a function of pH variation with the respective percentage estimates of α-helix structures. Black—pH 2.0 (13%); Red—pH 3.0 (20%); Azul—pH 4.0 (58%); Pink—pH 6.5 (86%); Green—pH 8.0 (46%); and Purple—pH 10.0 (28%).
Figure 5Representation of the action mechanism of annexins during MV-mediated mineralization: (A) AnxA6 can be localized in the lumen of MVs at low calcium concentrations (Ca2+). AnxA5 can be bound to membrane bilayer; (B) Accumulation of Ca2+ and inorganic phosphate (Pi) inside MVs favors the binding of AnxA6 to the inner leaflet of the MV membrane bilayer in a Ca2+-dependent manner, forming a nucleational core and initiating apatite formation; (C) During apatite formation, protons (H+) are released, inducing the protonation of AnxA6 and rendering it more hydrophobic due to an ionization potential around 5.5. Protonated AnxA6 can translocate within the MV bilayer; (D) Apatite crystals inside the vesicles continue growing up, breaking the membrane of MVs, exposing the HA crystals to the extracellular matrix, and releasing the H+ which decreases the local pH; (E) AnxA6 can be deprotonated and released to the external surface of MVs. (F) AnxA5 present in the membrane bilayer showed a high affinity to collagen binding. Thus, AnxA5 can promotes the adhesion of MVs to collagen fibers, allowing the deposition of the HA crystals on the extracellular matrix.